Cargando…

Response to Letter to the Editor from Lasolle and Raverot: “USP8 and TP53 Drivers Are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors”

Detalles Bibliográficos
Autores principales:	Uzilov, Andrew V, Geer, Eliza B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277217/ https://www.ncbi.nlm.nih.gov/pubmed/33822973 http://dx.doi.org/10.1210/clinem/dgab218

Ejemplares similares

Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma
por: Uzilov, Andrew V., et al.
Publicado: (2017)

Refractory corticotroph adenomas
por: Sumal, Amit K. S., et al.
Publicado: (2023)

Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas
por: Sbiera, Silviu, et al.
Publicado: (2016)

Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
por: Viola, David, et al.
Publicado: (2022)

Aggressive corticotroph tumors and carcinomas
por: Lasolle, Hélène, et al.
Publicado: (2022)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

Outcome Squares Integrating Efficacy and Safety, as Applied to Functioning Pituitary Adenoma Surgery
por: de Vries, Friso, et al.
Publicado: (2021)

The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness
por: Wang, Zihao, et al.
Publicado: (2020)

The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma
por: Ji, Chenxing, et al.
Publicado: (2022)

Response to Letter to the Editor: “Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History”
por: Schini, Marian, et al.
Publicado: (2020)

Response to Letter to the Editor: “Changes in Thyroid Function Across Adolescence: A Longitudinal Study”
por: Campbell, Purdey J, et al.
Publicado: (2020)

Response to Letter to the Editor: “Trends in Endocrinology Fellowship Recruitment: Reasons for Concern and Possible Interventions”
por: Romeo, Giulio R, et al.
Publicado: (2020)

Letter to the Editor: “Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment”
por: Allard, Neeltje A E, et al.
Publicado: (2020)

Response to Letter to the Editor: “IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction”
por: Joustra, Sjoerd D, et al.
Publicado: (2020)

Response to Letter to the Editor from Liu et al: “Evidence in Support for the Progressive Nature of Ovarian Endometriomas”
por: Liu, Xishi, et al.
Publicado: (2020)

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
por: Tsang, Venessa H M, et al.
Publicado: (2020)

Response to Letter to the Editor From Asa and Mete: “Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease”
por: Langlois, Fabienne, et al.
Publicado: (2022)

Response to Letter to the Editor from Soghomonian: “Epicardial and Pericardial Adiposity Without Myocardial Steatosis in Cushing Syndrome”
por: Wolf, Peter, et al.
Publicado: (2021)

Response to Letter to the Editor From Asadipooya: “Obesity and COVID-19: Mechanistic Insights From Adipose Tissue”
por: Yu, Lili, et al.
Publicado: (2022)

The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
por: Regazzo, Daniela, et al.
Publicado: (2022)

Correction to: Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management
Publicado: (2022)

A new molecular signature method for prediction of driver cancer pathways from transcriptional data
por: Rykunov, Dmitry, et al.
Publicado: (2016)

Long-Term Use of Temozolomide as Safe and Effective Therapy for an Aggressive Corticotroph Adenoma in a Very Old Patient
por: Decaroli, Maria Chiara, et al.
Publicado: (2021)

Response to Letter to the Editor from Berends et al: “Approach to the Patient: Perioperative Management of the Patient With Pheochromocytoma or Sympathetic Paraganglioma”
por: Berends, Annika M A, et al.
Publicado: (2020)

Letter to the Editor: “Lavender Products Associated With Premature Thelarche and Prepubertal Gynecomastia: Case Reports and Endocrine-Disrupting Chemical Activities”
por: Giroux, Jean-Marc, et al.
Publicado: (2020)

Response to Letter to the Editor From Bonnema et al: “Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine + Liothyronine in Hypothyroidism”
por: Shakir, Mohamed K M, et al.
Publicado: (2021)

Response to Letter to the Editor from Youn Hee Jee: “Familial Short Stature - A Novel Phenotype of Growth Plate Collagenopathies”
por: Plachy, Lukas, et al.
Publicado: (2021)

Response to Letter to the Editor From Jialal: “Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Disease: A Longitudinal Study”
por: Lee, Iris, et al.
Publicado: (2022)

Response to Letter to the Editor from Giovanelli and Quinton: “Distinguishing Self-limited Delayed Puberty From Permanent Hypogonadotropic Hypogonadism: How and Why?”
por: Harrington, Jennifer, et al.
Publicado: (2021)

Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”
por: Anastasilakis, Athanasios D, et al.
Publicado: (2022)

Response to Letter to the Editor From Cuny et al: “Correlation of Preoperative Imaging Findings and Parathyroidectomy Outcomes Support NICE 2019 Guidance”
por: Chander, Nikita R, et al.
Publicado: (2022)

Response to Letter to the Editor From Berruti et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival”
por: Srougi, Victor, et al.
Publicado: (2022)

Response to Letter to the Editor from Edmundo Avila-Hipolito: “Long-Term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity”
por: Pilli, Tania, et al.
Publicado: (2020)

Response to Letter to the Editor From Malozowski: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
por: Thornton, Paul S, et al.
Publicado: (2021)

Changing Cognitive Risk Factors for Sexual Aggression: Risky Sexual Scripts, Low Sexual Self-Esteem, Perception of Pornography, and Acceptance of Sexual Coercion
por: Schuster, Isabell, et al.
Publicado: (2020)

Response to Letter to the Editor from McKee and McGill: “Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring”
por: Juel, Caroline T B, et al.
Publicado: (2021)

Letter to the Editor From Grill et al: “Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial”
por: Grill, Valdemar, et al.
Publicado: (2021)

Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
por: Sävendahl, Lars, et al.
Publicado: (2021)

Response to Letter to the Editor from Roy et al: “Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function”
por: Chen, Xi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2o93tsnfdv58d5tj7vnpd6gmp1